MDGL
Madrigal Pharmaceuticals Inc
493.60$
-1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -267.1% | – | – | – | |
| – | +5.2% | +18.3% | +58.9% | +11.6% | +21.8% | +4.4% | -0.5% | +493.6% | -82.5% | -1.5% | -1.3% | – | |
| – | +17.3% | +34.0% | +22.6% | -26.7% | -1.2% | +18.4% | +20.2% | +4.3% | -1.8% | +31.9% | +4.0% | – | |
| – | +4,604.8% | -235.3% | – | – | -392.5% | – | – | – | -162.8% | – | – | – | |
| – | +205.6% | -65.5% | +1,337.3% | -84.8% | -75.0% | -100.0% | – | – | -54.5% | +886.9% | +10.5% | – | |
| – | -821.4% | – | -224.5% | +65.8% | -76.3% | – | -70.8% | -532.5% | – | +596.8% | -82.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,351.1% | +19.5% | -76.6% | -94.4% | +165.0% | -56.3% | -79.8% | +13,492.6% | -96.2% | -74.0% | +33.6% | – | |
| – | – | +1,280.4% | -123.5% | – | – | – | -97.0% | +4,199.2% | -188.5% | – | +113.7% | – | |
| – | – | – | – | – | – | – | – | – | -268.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.